We just had an API AFB survey where the specimen was put on the back of the slide... Not the labeled side. After the staining process, the specimen circle didn’t take on any color and nothing would come in focus. I stained the other side and sure enough, positive!!!! API’s response, is we should notice where the specimen is regardless of the labeling!
I was wondering if anyone knew of a report that showed incident rate of FDA reportable events per hospital or per other statistic like transfusions, patients, etc... Just looking for a baseline to see how our facility compares to others. I have searched and reached out to other facilities and haven't had any luck. Thanks in advance.
The 2017 revisions were released this week. The computer crossmatch section was revised to align with the FDA guidance.
"If ABO typing discrepancies exist, you should not rely on a computer crossmatch.This is particularly important if there is mixed field red cell reactivity, missing serum reactivity, or apparent change in blood type following hematopoietic stem cell transplantation.Under those circumstances, your procedures should provide for compatibility testing using serologic crossmatch techniques."
I called CAP to verify that this included resolved ABO discrepancies. Our hospital had been allowing computer crossmatches for ABO discrepancies that are resolved, and I'm not sure that our BB LIS could prevent a patient with a resolved ABO discrepancy from receiving a computer crossmatch.
Does your LIS prevent computer crossmatches for patients with MF reactions or weak reverses?
I need some guidance! I did a quick search of the forums for any discussion about this, and the most current posting was in 2010. I'm wondering if anyone has any new information, new experiences, or any advice about CAP TRM.40120. The note states "...all analysts participate in QC on a regular basis."
How frequently is "regular"? For example, when I was looking to complete our annual Competency assessment in September (don't ask...), I was looking for evidence that each individual who performs MTS testing had performed MTS QC. There were some employees who had not performed MTS QC yet in 2016. I'm inclined to say that someone who hasn't performed QC in at least 8+ months is not participating in QC on a regular basis. Being new to my role, I'm just not sure how the assessors interpret this standard, and how others provide evidence of compliance.